Literature DB >> 9925216

Intrapericardial neoplasia in dogs.

C Girard1, P Hélie, M Odin.   

Abstract

A retrospective study was conducted from 1,919 necropsies of dogs, and 52 cases were selected on the basis of primary or metastatic neoplasia in the pericardium, the heart base, or the myocardium. Primary intrapericardial neoplasms were more frequent than intrapericardial metastases. Hemangiosarcomas were the most frequent primary neoplasms, followed by chemodectomas. Lymphomas were the most frequent metastatic neoplasms, followed by fibrosarcomas and rhabdomyosarcomas. Other neoplasms, either primary or metastatic, occurred rarely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925216     DOI: 10.1177/104063879901100112

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  5 in total

1.  Investigating the sudden death of a dog.

Authors:  N Jane Harms; Bruce B Guest; Andrew L Allen
Journal:  Can Vet J       Date:  2010-02       Impact factor: 1.008

2.  Ectopic thyroid carcinoma infiltrating the right atrium of the heart in a dog.

Authors:  Min-Hee Kang; Dae-Young Kim; Hee-Myung Park
Journal:  Can Vet J       Date:  2012-02       Impact factor: 1.008

3.  Total venous inflow occlusion and pericardial auto-graft reconstruction for right atrial hemangiosarcoma resection in a dog.

Authors:  Fei Verbeke; Dominique Binst; Ludo Stegen; Tim Waelbers; Hilde de Rooster; Bart Van Goethem
Journal:  Can Vet J       Date:  2012-10       Impact factor: 1.008

4.  Epidemiological, clinical and pathological features of primary cardiac hemangiosarcoma in dogs: a review of 51 cases.

Authors:  Shinya Yamamoto; Katsuichiro Hoshi; Atsushi Hirakawa; Syuuichi Chimura; Masayuki Kobayashi; Noboru Machida
Journal:  J Vet Med Sci       Date:  2013-06-28       Impact factor: 1.267

5.  Use of multidetector computed tomography in the assessment of dogs with pericardial effusion.

Authors:  K F Scollan; B Bottorff; S Stieger-Vanegas; S Nemanic; D Sisson
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.